Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

Microbiome Therapies Show Potential in Food Allergy Research

Sublingual Epinephrine Advances as FDA Clarifies Requirements for Approval

Experimental KIC-IT Protocol Shows Early Success in Reversing Infant Food Allergies

Dupilumab Shows Promise for Patients Struggling With OIT Side Effects

Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Intranasal Peanut Allergy Vaccine Takes Step Forward

Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial

Food Allergy Prevention QuickFire Challenge: Up to $150,000 in Grant Funding...

FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine

Your School On Our Map

Put Your School on the Map